These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 36045668)

  • 1. B7H3-dependent myeloid-derived suppressor cell recruitment and activation in pulmonary fibrosis.
    Liu T; Gonzalez De Los Santos F; Rinke AE; Fang C; Flaherty KR; Phan SH
    Front Immunol; 2022; 13():901349. PubMed ID: 36045668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B7H3 expression and significance in idiopathic pulmonary fibrosis.
    Fang C; Rinke AE; Wang J; Flaherty KR; Phan SH; Liu T
    J Pathol; 2022 Mar; 256(3):310-320. PubMed ID: 34825713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of B7H3/IL-33 Signaling in Pulmonary Fibrosis-induced Profibrogenic Alterations in Bone Marrow.
    Nakashima T; Liu T; Hu B; Wu Z; Ullenbruch M; Omori K; Ding L; Hattori N; Phan SH
    Am J Respir Crit Care Med; 2019 Oct; 200(8):1032-1044. PubMed ID: 31106564
    [No Abstract]   [Full Text] [Related]  

  • 4. Myeloid-derived Suppressor Cells Are Necessary for Development of Pulmonary Hypertension.
    Bryant AJ; Shenoy V; Fu C; Marek G; Lorentsen KJ; Herzog EL; Brantly ML; Avram D; Scott EW
    Am J Respir Cell Mol Biol; 2018 Feb; 58(2):170-180. PubMed ID: 28862882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood myeloid-derived suppressor cells reflect disease status in idiopathic pulmonary fibrosis.
    Fernandez IE; Greiffo FR; Frankenberger M; Bandres J; Heinzelmann K; Neurohr C; Hatz R; Hartl D; Behr J; Eickelberg O
    Eur Respir J; 2016 Oct; 48(4):1171-1183. PubMed ID: 27587556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocytic Myeloid-Derived Suppressor Cells Inhibit Myofibroblastic Differentiation in Mesenchymal Stem Cells Through IL-15 Secretion.
    Cheuk YC; Xu S; Zhu D; Luo Y; Chen T; Chen J; Li J; Shi Y; Zhang Y; Rong R
    Front Cell Dev Biol; 2022; 10():817402. PubMed ID: 35252184
    [No Abstract]   [Full Text] [Related]  

  • 7. PPP1R15A-expressing monocytic MDSCs promote immunosuppressive liver microenvironment in fibrosis-associated hepatocellular carcinoma.
    Liu X; Liu M; Wu H; Tang W; Yang W; Chan TTH; Zhang L; Chen S; Xiong Z; Liang J; Wai-Yiu Si-Tou W; Shu T; Li J; Cao J; Zhong C; Sun H; Kwong TT; Leung HHW; Wong J; Bo-San Lai P; To KF; Xiang T; Jao-Yiu Sung J; Chan SL; Zhou J; Sze-Lok Cheng A
    JHEP Rep; 2024 Jul; 6(7):101087. PubMed ID: 38882672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified method for differentiation of myeloid-derived suppressor cells
    Zhou H; Xie Z; Morikawa N; Sakurai F; Mizuguchi H; Okuzaki D; Okada N; Tachibana M
    Biochem Biophys Rep; 2023 Mar; 33():101416. PubMed ID: 36605123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
    Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
    J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of Monocytic Myeloid-Derived Suppressor Cells in Patients Under Hemodialysis Might Lead to Cardiovascular and Cerebrovascular Events.
    Xing YF; Cai JR; Qin JJ; Zhou WY; Li CM; Li X
    Front Immunol; 2020; 11():577253. PubMed ID: 33584644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An In Vivo Mouse Model for Chronic Inflammation-Induced Immune Suppression: A "Factory" for Myeloid-Derived Suppressor Cells (MDSCs).
    Ben-Meir K; Twaik N; Meirow Y; Baniyash M
    Curr Protoc; 2022 Sep; 2(10):e558. PubMed ID: 36239438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum and bronchoalveolar lavage fluid levels of soluble B7H3 in patients with interstitial lung diseases.
    Nakashima T; Omori K; Namba M; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Hattori N
    Respir Med; 2023 Jun; 212():107224. PubMed ID: 37003499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mTOR Deficiency in Monocytic Myeloid-Derived Suppressor Cells Protects Mouse Cardiac Allografts by Inducing Allograft Tolerance.
    Li J; Chen J; Zhang M; Zhang C; Wu R; Yang T; Qiu Y; Liu J; Zhu T; Zhang Y; Rong R
    Front Immunol; 2021; 12():661338. PubMed ID: 33897705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential role of stem cell factor-c-Kit signalling pathway in bleomycin-induced pulmonary fibrosis.
    Ding L; Dolgachev V; Wu Z; Liu T; Nakashima T; Wu Z; Ullenbruch M; Lukacs NW; Chen Z; Phan SH
    J Pathol; 2013 Jun; 230(2):205-14. PubMed ID: 23401096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitigating the prevalence and function of myeloid-derived suppressor cells by redirecting myeloid differentiation using a novel immune modulator.
    Oliver L; Alvarez R; Diaz R; Valdés A; Colligan SH; Nemeth MJ; Twum DYF; Fernández A; Fernández-Medina O; Carlson LM; Yu H; Eng KH; Hensen ML; Rábade-Chediak ML; Fernández LE; Lee KP; Perez L; Muhitch JB; Mesa C; Abrams SI
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36150744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-Small Cell Lung Cancer.
    Yamauchi Y; Safi S; Blattner C; Rathinasamy A; Umansky L; Juenger S; Warth A; Eichhorn M; Muley T; Herth FJF; Dienemann H; Platten M; Beckhove P; Utikal J; Hoffmann H; Umansky V
    Am J Respir Crit Care Med; 2018 Sep; 198(6):777-787. PubMed ID: 29617574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical association of programmed death-1/PD-L1 axis, myeloid derived suppressor cells subsets and regulatory T cells in peripheral blood of stable COPD patients.
    Zhang M; Wan Y; Han J; Li J; Gong H; Mu X
    PeerJ; 2024; 12():e16988. PubMed ID: 38560459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Cell RNA-seq of Human Myeloid-Derived Suppressor Cells in Late Sepsis Reveals Multiple Subsets With Unique Transcriptional Responses: A Pilot Study.
    Darden DB; Bacher R; Brusko MA; Knight P; Hawkins RB; Cox MC; Dirain ML; Ungaro R; Nacionales DC; Rincon JC; Gauthier ML; Kladde M; Bihorac A; Brusko TM; Moore FA; Brakenridge SC; Mohr AM; Moldawer LL; Efron PA
    Shock; 2021 May; 55(5):587-595. PubMed ID: 33021571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Levels of Monocytic Myeloid-Derived Suppressor Cells (M-MDSC) and CXCL-8 in Non-Small Cell Lung Cancer (NSCLC).
    Zadian SS; Adcock IM; Salimi B; Mortaz E
    Tanaffos; 2021 Jan; 20(1):15-21. PubMed ID: 34394365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Myeloid-Derived Suppressor Cell Subsets in Patients with Colorectal Cancer - Exploratory Analysis of Their Biomarker Potential.
    Fědorová L; Pilátová K; Selingerová I; Bencsiková B; Budinská E; Zwinsová B; Brychtová V; Langrová M; Šefr R; Valík D; Zdražilová Dubská L
    Klin Onkol; 2018; 31(Suppl 2):88-92. PubMed ID: 31023030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.